CD8A and neoplasm: Existing literature supported the notion that both immunotherapy and chemotherapy can promote the development of tertiary lymphoid structures, including the proliferation of CD8+ T cells, thereby bolstering anti-tumor immunity (Cabrita et al., 2020; Helmink et al., 2020; Vanhersecke et al., 2021; Lee et al., 2022).